Michael D. Schreiber to Retinopathy of Prematurity
This is a "connection" page, showing publications Michael D. Schreiber has written about Retinopathy of Prematurity.
Connection Strength
0.175
-
Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
Score: 0.157
-
Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr. 2008 Aug; 153(2):183-9.
Score: 0.018